Impact of IVDR for LC-MS LDTs in the clinical lab

The In Vitro Diagnostic Regulation (IVDR) is the European Union’s set of rules aimed at improving the quality, safety, and reliability of IVDs. The regulation affects clinical laboratories using their own in-house testing - “Laboratory Developed Tests” (LDTs).

Join LC-MS expert Magali Wolff, Head of Global Reagent Marketing and Support at Tecan, to understand the IVDR requirements, broken down and explained by key sections; learn about the LC-MS landscape today and the vision for tomorrow; and find out what the next vital steps are for your diagnostic laboratory.

This webinar is recommended for clinical professionals and LC-MS specialists who would like to learn more about the impact of IVDR on LC-MS/MS laboratories using LDTs.

Key learning objectives

• What is IVDR and what is the key timeline?
• What are the requirements for in-house tests (LDTs)?
• What are the crucial next steps for your lab?

Who should attend?

• Clinical laboratory managers and directors
• Clinical LC-MS specialists
• Principal investigators, lab owners, and researchers at LC-MS laboratories
• Professionals interested in the IVDR topic

Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes. Webinars are suitable for self-certified CPD activities for IBMS and HCPC portfolios.